erlotinib hydrochloride has been researched along with Choroid Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kaliki, S; Padhy, SK | 1 |
| Huh, K; Kim, MJ; Kim, SW; Oh, J | 1 |
| Fujiu, K; Kobayashi, N; Miyamoto, H; Suzuki, H | 1 |
3 other study(ies) available for erlotinib hydrochloride and Choroid Neoplasms
| Article | Year |
|---|---|
Incidental finding of regressed solitary unilateral choroidal metastasis from lung adenocarcinoma with EGFR exon-19 deletion treated with erlotinib.
Topics: Adenocarcinoma; Antineoplastic Agents; Base Sequence; Biomarkers, Tumor; Choroid Neoplasms; Erlotinib Hydrochloride; Exons; Female; Genes, erbB-1; Humans; Incidental Findings; Lung Neoplasms; Middle Aged; Sequence Deletion | 2021 |
Complete regression of choroidal metastasis secondary to non-small-cell lung cancer with intravitreal bevacizumab and oral erlotinib combination therapy.
Topics: Administration, Oral; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Carcinoma, Non-Small-Cell Lung; Choroid Neoplasms; Drug Therapy, Combination; Erlotinib Hydrochloride; Female; Humans; Injections, Intraocular; Lung Neoplasms; Middle Aged; Protein Kinase Inhibitors; Quinazolines; Remission Induction; Vitreous Body | 2009 |
A case of choroidal metastasis of lung cancer successfully treated with erlotinib.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Choroid Neoplasms; Erlotinib Hydrochloride; Female; Humans; Lung Neoplasms; Middle Aged; Neovascularization, Pathologic; Protein Kinase Inhibitors; Quinazolines | 2012 |